The TRISCEND II clinical trial is to determine the safety and effectiveness of the EVOQUE valve, a device designed to replace the tricuspid valve with no open heart surgery. This trial is for patients with severe or greater tricuspid regurgitation.
edwards clinical trial
edwards heart clinical trial
evoque clinical trial
evoque tricuspid valve replacement system
evoque valve
evoque valve replacement
Greater tricuspid regurgitation
heart valve clinical trial
noninvasive tricuspid replacement
Severe Tricuspid Regurgitation
severe tricuspid valve regurgitation
transcatheter tricuspid valve
transcatheter tricuspid valve repair
transcatheter tricuspid valve repair
transcatheter valve repair
tricuspid clinical trial
tricuspid insufficiency
Tricuspid Regurgitation
tricuspid regurgitation signs and symptoms
tricuspid regurgitation symptoms
tricuspid regurgitation treatment
tricuspid surgery
tricuspid valve clinical trial
tricuspid valve clinical trial
tricuspid valve defect
tricuspid valve insufficiency
tricuspid valve leak
Tricuspid Valve Regurgitation
tricuspid valve regurgitation
tricuspid valve repair
Tricuspid Valve Replacement
tricuspid valve replacement video
tricuspid valvular insufficiency
triscend clinical trial
triscend II clinical trial
valve regurgitation treatment
AS